Morgan Stanley’s Westlake Chemical Partners WLKP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.99M Sell
180,571
-12,667
-7% -$272K ﹤0.01% 4302
2025
Q4
$3.67M Buy
193,238
+30,668
+19% +$592K ﹤0.01% 4409
2025
Q3
$3.41M Buy
162,570
+10,942
+7% +$240K ﹤0.01% 4437
2025
Q2
$3.35M Sell
151,628
-10,887
-7% -$247K ﹤0.01% 4375
2025
Q1
$3.75M Sell
162,515
-77,767
-32% -$1.85M ﹤0.01% 4167
2024
Q4
$5.56M Buy
240,282
+32,729
+16% +$751K ﹤0.01% 3902
2024
Q3
$4.65M Sell
207,553
-45,388
-18% -$1.03M ﹤0.01% 4015
2024
Q2
$5.71M Buy
252,941
+63,424
+33% +$1.41M ﹤0.01% 3777
2024
Q1
$4.21M Sell
189,517
-208,979
-52% -$4.69M ﹤0.01% 4041
2023
Q4
$8.63M Buy
398,496
+263,296
+195% +$5.74M ﹤0.01% 4035
2023
Q3
$2.94M Buy
135,200
+3,202
+2% +$71.6K ﹤0.01% 4115
2023
Q2
$2.86M Sell
131,998
-25,536
-16% -$559K ﹤0.01% 4184
2023
Q1
$3.47M Buy
157,534
+38,124
+32% +$894K ﹤0.01% 4082
2022
Q4
$2.81M Buy
119,410
+19,622
+20% +$445K ﹤0.01% 4227
2022
Q3
$2.15M Sell
99,788
-14,476
-13% -$350K ﹤0.01% 4378
2022
Q2
$2.85M Sell
114,264
-38,943
-25% -$1.04M ﹤0.01% 4256
2022
Q1
$4.15M Buy
153,207
+13,562
+10% +$360K ﹤0.01% 3887
2021
Q4
$3.75M Sell
139,645
-74,008
-35% -$1.84M ﹤0.01% 4020
2021
Q3
$5.2M Sell
213,653
-69,102
-24% -$1.81M ﹤0.01% 3648
2021
Q2
$7.61M Buy
282,755
+51,606
+22% +$1.37M ﹤0.01% 3309
2021
Q1
$5.55M Sell
231,149
-65,453
-22% -$1.54M ﹤0.01% 3297
2020
Q4
$7.07M Sell
296,602
-179,694
-38% -$3.64M ﹤0.01% 2881
2020
Q3
$8.93M Buy
476,296
+30,766
+7% +$610K ﹤0.01% 2128
2020
Q2
$8.44M Sell
445,530
-68,625
-13% -$1.25M ﹤0.01% 2123
2020
Q1
$7.6M Buy
514,155
+14,237
+3% +$298K ﹤0.01% 2035
2019
Q4
$13.2M Sell
499,918
-126,265
-20% -$2.9M ﹤0.01% 2094
2019
Q3
$14.6M Sell
626,183
-79,751
-11% -$1.81M ﹤0.01% 1770
2019
Q2
$17.4M Buy
705,934
+138,617
+24% +$3.2M ﹤0.01% 1599
2019
Q1
$12.9M Buy
567,317
+98,775
+21% +$2.25M ﹤0.01% 1790
2018
Q4
$11.3M Buy
468,542
+273,467
+140% +$6.32M ﹤0.01% 2002
2018
Q3
$4.86M Sell
195,075
-77,682
-28% -$1.97M ﹤0.01% 3208
2018
Q2
$6.68M Sell
272,757
-318,656
-54% -$7.41M ﹤0.01% 2821
2018
Q1
$13.2M Sell
591,413
-932,350
-61% -$22M ﹤0.01% 2074
2017
Q4
$38M Buy
1,523,763
+190,423
+14% +$4.3M 0.01% 1129
2017
Q3
$30.3M Buy
1,333,340
+558,532
+72% +$13.5M 0.01% 1248
2017
Q2
$19.2M Sell
774,808
-9,030
-1% -$223K 0.01% 1571
2017
Q1
$19.7M Sell
783,838
-301,213
-28% -$7.29M 0.01% 1582
2016
Q4
$23.5M Sell
1,085,051
-19,403
-2% -$416K 0.01% 1393
2016
Q3
$25.2M Sell
1,104,454
-56,655
-5% -$1.29M 0.01% 1287
2016
Q2
$23.2M Buy
1,161,109
+12,238
+1% +$245K 0.01% 1308
2016
Q1
$22.6M Sell
1,148,871
-480,374
-29% -$8.92M 0.01% 1234
2015
Q4
$36.1M Sell
1,629,245
-29,930
-2% -$542K 0.01% 992
2015
Q3
$29M Buy
1,659,175
+781,846
+89% +$16.1M 0.01% 1116
2015
Q2
$19.1M Sell
877,329
-123,755
-12% -$2.97M 0.01% 1537
2015
Q1
$26.8M Buy
1,001,084
+143,419
+17% +$3.77M 0.01% 1225
2014
Q4
$24.9M Sell
857,665
-78,596
-8% -$2.25M 0.01% 1295
2014
Q3
$27.2M Buy
+936,261
New +$28.4M 0.01% 1202

Other funds holding WLKP

Morgan Stanley's WLKP Position: Q1 2026 in Review

Morgan Stanley reduced its Westlake Chemical Partners (WLKP) stake by 6.6% in Q1 2026, selling an estimated $272K and leaving 180,571 shares worth $3.99M. The position accounts for ﹤0.01% of the portfolio, ranked #4302.

Morgan Stanley first reported a position in WLKP in Q3 2014 and has held it in 47 quarters since. The position peaked at $38M in Q4 2017. 57 funds tracked by Wall St. Rank hold WLKP as of Q1 2026.

  • Morgan Stanley held 180,571 shares of Westlake Chemical Partners worth $3.99M as of Q1 2026.
  • Morgan Stanley sold 12,667 Westlake Chemical Partners shares in Q1 2026, an estimated $272K.
  • Westlake Chemical Partners made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #4302 holding.
  • Morgan Stanley first reported a position in Westlake Chemical Partners in Q3 2014 and has held it in 47 quarters since.
  • Morgan Stanley's Westlake Chemical Partners position peaked at $38M in Q4 2017.
  • 57 funds tracked by Wall St. Rank held Westlake Chemical Partners as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.